Puma Biotechnology Dividends
| PBYI Stock | USD 6.06 -0.16 -2.57% |
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 588.76 | 618.20 |
Puma |
Dividend history for Puma Biotechnology is limited, so ex-dividend dates provide added context. Ex-dividend dates are useful reference points for distribution timing.
About Puma Biotechnology Dividends Analysis
Dividend data for Puma Biotechnology is limited, so coverage and policy carry more weight than long history.
Unless otherwise specified, financial data for Puma Biotechnology is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Puma Biotechnology may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Quarterly Earnings Growth -0.34 | Earnings Share 0.61 | Revenue Per Share | Quarterly Revenue Growth 0.277 | Return On Assets |
The market value of Puma Biotechnology is measured differently than book value, which reflects Puma accounting equity. Puma Biotechnology's market capitalization is 308.31 M. A P/B ratio of 2.37 indicates the market values Puma Biotechnology above its accounting book value. Enterprise value stands at 239.33 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Puma Biotechnology's intrinsic value and market price are different measures derived from different inputs. For Puma Biotechnology, key inputs include a P/E ratio of 18.52, a P/B ratio of 2.37, a profit margin of 13.62%, ROE of 27.97%. By contrast, market price reflects the level where buyers and sellers transact.